Patent ID: 9248112
Filing Date: 2016-02-02
CPC Classification: A61K,A61P

Claim Text:
1. A hemodialysis or peritoneal dialysis solution comprising one or more compounds selected from the group consisting of: (i) creatine; (ii) (phospho)creatine; (iii) (phospho)cyclocreatine; (iv) homocyclocreatine; (v) (phospho)creatine monohydrate; (vi) guanidinoacetic acid; (vii) 3-guanidinopropionic acid; (viii) guanidino benzoic acid; (ix) a combination of glycine, arginine and methionine; and (x) a physiologically acceptable salt of any of (i) through (ix); wherein said one or more compounds are present in the hemodialysis or peritoneal dialysis solution at a concentration equivalent to from 0.002 to 45 mM creatine, wherein the hemodialysis or peritoneal dialysis solution further comprises physiologically acceptable concentrations of sodium and chloride ions, and at least one physiologically acceptable buffering substance, and wherein the hemodialysis or peritoneal dialysis solution does not contain concentrations of any substances that would make the hemodialysis or peritoneal dialysis solution physiologically unacceptable.